Oncology, immunology & rheumatology, rare diseases and CNS are perceived of high commercial attractiveness by respondents in the next 5 years
Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · page 27 of 58
The chart uses a 7-point Likert scale. The top 4 categories are highlighted in green.
Consulting deck · market_landscape · analyze_data · overcrowded density
Slide locked Sign in to view
Slide schematic 6/9
callout 0/1 chart 1/1 disclaimer 1/1 metric 0/1 quote 1/2 source-note 1/1 title 2/2
3 without position callout 1 · metric 1 · quote 1
calloutmetric · primaryquote
Components 9
callout bar-horizontal disclaimer primary testimonial quote source-note headline subtitle
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 1
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.